Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NB2004 Risk-Adapted Treatment of Children with Neuroblastoma
DRKS00001038Phase 4Completed
- Sponsor
- Uniklinik Köln
- Start
- May 2012
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 2
01
Overview
Phase 4 trial of doxorubicin, vincristine, cyclophosphamide, cisplatin, etoposide and 4 more in neuroblastoma and Malignant Neoplasm Of Adrenal Gland (3 arms), sponsored by Uniklinik Köln. Started May 2012; status: completed.
02
Drugs
doxorubicinvincristinecyclophosphamidecisplatinetoposide
03
Conditions
neuroblastomaMalignant Neoplasm Of Adrenal Gland
Beyond the preview
Go deeper on DRKS00001038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00001038.